NCT04691505View on ClinicalTrials.gov

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine

CompletedOBSERVATIONAL
Enrollment

133,553

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Methotrexate

Methotrexate is used as the reference group.

DRUG

Hydroxychloroquine

Hydroxychloroquine is used as the exposure group.

Trial Locations (1)

02120

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Rutgers University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT04691505 - Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Methotrexate vs Hydroxychloroquine | Biotech Hunter | Biotech Hunter